Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

TFC-003

Phase 3Small molecule

TFC-003 is one of 42 small molecule programs targeting Glaucoma. It is currently in Phase 3.

1

Indications

2

Total Trials

1

Active Trials

41

Competitors

Pipeline

Status by Indication[3][1]

Indication

GlaucomaRecruiting

GlaucomaPhase 3

Recruiting

Competition

Competitive Landscape

54 competitors in Glaucoma

#DrugCompanyPhaseTrials

Alphagan

Zolymbus

Travatan

Xalatan

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Crestor

Timolol Maleate

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Diamox

Neoral

Decadron

AAspen Global Incorporated

Tobrex

VViatris Specialty LLC

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2027

Phase 3Recruiting

Glaucoma

NCT07662759

Clinical

Trials by Indication[1]

Ocular Hypertension1 trial

A Randomized, Open-label, Active-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Unknown status·KKukje Pharma·Phase 2·NCT06177678·60 enrolled

Glaucoma1 trial

A Prospective, Multicenter, Randomized, Investigator-Masked, Active-Controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Recruiting·KKukje Pharma·Phase 3·NCT07662759·188 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for TFC-003. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — TFC-003 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for TFC-003. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Kukje Pharma company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: KKukje Pharma

Related News